PHARMALACT® 21 AN stands as a distinctive anhydrous lactose variant, presenting itself in the form of white to off-white crystalline particles or powder. Comprising 70–80% anhydrous β-lactose and 20–30% anhydrous α-lactose, this dehydrated form of milk sugar holds significance in both pharmaceutical and food applications.

In the pharmaceutical realm, PHARMALACT® 21 AN acts as a versatile excipient, contributing to the mechanical stability and disintegration properties of oral solid dosage forms. Its role extends to tablet and capsule production, allowing for the precise dosing of active pharmaceutical ingredients. Meanwhile, within the food industry, it serves as a functional component, functioning as a bulking agent, sweetening agent, or texturizing agent in various products like powdered beverages, confections, and baked goods.

Manufactured through controlled drying methods, PHARMALACT® 21 AN emerges as a fine, white powder with superior stability and reduced susceptibility to caking. Despite its advantageous properties, it is crucial to note that individuals with lactose intolerance should exercise caution due to its retained lactose content. In pharmaceutical formulations, it is employed as a directly compressible tablet excipient, dry powder inhaler carrier, lyophilization aid, diluent, filler, and binder for tablets and capsules.